Title:Peculiarities of Bioaccumulation and Toxic Effects Produced by Nanoparticles
of Molybdenum (VI) Oxide under Multiple Oral Exposure of Rats:
Examination and Comparative Assessment
Volume: 10
Issue: 5
Author(s): Nina Vladimirovna Zaitseva, Marina Aleksandrovna Zemlyanova*, Mark Sergeevich Stepankov, Anna Mikhailovna Ignatova, Olga Vasilievna Pustovalova and Alyona Evgenievna Nikolaeva
Affiliation:
- Department of Biochemical and Cytogenetics Diagnostics, Federal Scientific Center for Medical and Preventive Health
Risk Management Technologies, Perm, Russia
- Perm State National Research University, Perm, Russia
- Perm National
Research Polytechnic University, Perm, Russia
Keywords:
Molybdenum (VI) oxide, nanoparticles, microparticles, oral exposure, toxicity, rats.
Abstract:
Introduction: Molybdenum (VI) oxide nanoparticles (MoO3 NPs) are widely used in various
economic activities. This creates elevated risks of exposure to this nanomaterial for workers and
the population in general, and consequently, there can be an increased number of developing pathological
changes caused by exposure to MoO3 NPs.
Objective: The study aims to examine and comparatively assess peculiarities of bioaccumulation and
toxic effects produced by MoO NPs under multiple oral introductions.
Methods: We evaluated the sizes of analyzed particles by scanning electronic microscopy; the specific
surface area was calculated by the method of Brunauer, Emmett and Taylor; the total pore volume by
Barrett, Joyner and Halenda. Rats were exposed as per the scheme introduced by Lim with colleagues.
We examined biochemical and hematological blood indicators, molybdenum concentrations, and
pathomorphological changes in tissues of various organs 24 hours after the last exposure. The study
involved a comparison with effects produced by MoO3 microparticles.
Results: The tested MoO3 sample was established to be a nanomaterial as per the whole set of its
physical properties. 50% of animals in the exposed group died on the 16th day of the experiment after
the total exposure dose of MoO3 NPs reached 6500 mg/kg of body weight. Having analyzed blood
plasma, we determined the following. There was a growth in the quantity of leukocytes and a share of
segmented neutrophils and monocytes, which were 1.76-3.50 times higher than in the control group.
Activity of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gammaglutamyl
transpeptidase, alpha-amylase, and lactate dehydrogenase, and concentrations of urea, crude
and direct bilirubin was higher by 1.61-22.86 times. Decrease in the number of platelets, plateletcrit,
the relative number of lymphocytes, and the number and proportion of large platelets by 1.31-2.71
times. We detected elevated molybdenum concentrations in the lungs, heart, liver, kidneys, brain, and
blood under exposure to MoO3 NPs, exceeding the control values by 12.10-361.75 times. Rats exposed
to MoO3 NPs had liver parenchymal steatosis, inflammatory changes, hemorrhagic infarctions,
and hyperplasia in the lungs.
Conclusion: MoO3 NPs are more able to bioaccumulate and produce toxic effects compared with their
microdispersed analogue under multiple oral introductions into the body.